menu

QuintilesIMS Blog

Fresh ideas and insights from our experts around the globe

trnd-sickle-cell-556px - image courtesy of NIH
How patient reported outcomes and global trials are giving new hope to sickle cell disease patients who haven’t seen a new treatment in decades.
PatrickJordan
In the new era of clinical development, decisions are all data driven, and the mistakes that add millions of dollars to drug development projects will soon be a distant memory.
Read More
Siva Nadarajah
A new platform to validate social media trends is helping biopharmaceutical companies make the most of this valuable source of data.
Read More
Ray Huml
Stephen Evans
Selecting the right commercial site for an early phase trial.
Read More
Anke van Engen
How the Japanese government’s efforts to rein-in pharma spending will effect drug prices across the country.
Read More
Kimberly Ray
How evidence-based decision making and working differently improves patient enrollment in clinical trials.
Read More
Daniel Vazquez
Latin America is a center for biopharmaceutical growth, but shifting regulations mean companies need keen insights and boots on the ground to navigate this complex marketplace.
Read More
Barbara Gillespie
Many of the individual diseases that collectively represent ‘kidney disease’ are themselves rare diseases.
Read More
Peter Rutherford
CynthiaJackson